Jacobs Levy Equity Management
AUXL

Jacobs Levy Equity Management’s AUXILIUM PHARAMCEUTICALS INC AUXL Stock Holding History

Jacobs Levy Equity Management’s Portfolio AUXL Stock Details AUXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-7,730
Closed -$210K – 1025
2014
Q1 		$210K Sell
7,730
-25,470
-77% -$676K ﹤0.01% 816
2013
Q4 		$688K Sell
33,200
-117,169
-78% -$2.21M 0.01% 657
2013
Q3 		$2.74M Buy
150,369
+62,360
+71% +$1.13M 0.05% 373
2013
Q2 		$1.46M Buy
+88,009
New +$1.41M 0.03% 490

Other funds holding AUXL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Jacobs Levy Equity Management's AUXL Position: Q2 2014 in Review

Jacobs Levy Equity Management sold out of AUXILIUM PHARAMCEUTICALS INC (AUXL) in Q2 2014, closing a stake of 7,730 shares — an estimated $210K sold.

Jacobs Levy Equity Management first reported a position in AUXL in Q2 2013 and held it in 4 quarters. The position peaked at $2.74M in Q3 2013. 152 funds tracked by Wall St. Rank hold AUXL as of Q2 2014.

  • Jacobs Levy Equity Management reported no remaining AUXILIUM PHARAMCEUTICALS INC position as of Q2 2014 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 7,730 AUXILIUM PHARAMCEUTICALS INC shares in Q2 2014, an estimated $210K.
  • Jacobs Levy Equity Management first reported a position in AUXILIUM PHARAMCEUTICALS INC in Q2 2013 and held it in 4 quarters.
  • Jacobs Levy Equity Management's AUXILIUM PHARAMCEUTICALS INC position peaked at $2.74M in Q3 2013.
  • 152 funds tracked by Wall St. Rank held AUXILIUM PHARAMCEUTICALS INC as of Q2 2014.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2014, filed 14 Aug 2014.